HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Examination of lipid profiles in abdominal fascial healing using MALDI-TOF to identify potential therapeutic targets.

AbstractBACKGROUND:
Failure of fascial healing in the abdominal wall can result in incisional hernia, which is one of the most common complications after laparotomy. Understanding the molecular healing process of abdominal fascia may provide lipid markers of incisional hernia or therapeutic targets that allow prevention or treatment of incisional hernias.
PURPOSE:
This study aims to investigate temporal and in situ changes of lipids during the normal healing process of abdominal fascia in the first postoperative week.
METHODS:
Open hemicolectomy was performed in a total of 35 Wistar rats. The midline fascia was closed identically for all rats using a single continuous suturing technique. These animals were sacrificed with equal numbers (n = 5) at each of 7-time points (6, 12, 24, 48, 72, 120, and 168 h. The local and temporal changes of lipids were examined with mass spectrometry imaging and correlated to histologically scored changes during healing using hematoxylin and eosin staining.
RESULTS:
Two phosphatidylcholine lipid species (PC O-38:5 and PC 38:4) and one phosphatidylethanolamine lipid (PE O-16:1_20:4) were found to significantly correlate with temporal changes of inflammation. A phosphatidylcholine (PC 32:0) and a monosialodihexosylganglioside (GM3 34:1;2) were found to correlate with fibroblast cell growth.
CONCLUSION:
Glycerophospholipids and gangliosides are strongly involved in the normal healing process of abdominal fascia and their locally fluctuating concentrations are considered as potential lipid markers and therapeutic targets of fascial healing.
AuthorsHong Liu, Jianhua Cao, Benjamin Balluff, Audrey C H M Jongen, Marion J Gijbels, Jarno Melenhorst, Ron M A Heeren, Nicole D Bouvy
JournalJournal of mass spectrometry and advances in the clinical lab (J Mass Spectrom Adv Clin Lab) Vol. 20 Pg. 35-41 (Apr 2021) ISSN: 2667-145X [Electronic] Netherlands
PMID34820669 (Publication Type: Journal Article)
Copyright© 2021 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: